Analyst Tracker/Joseph Pantginis

Joseph Pantginis

Q: How accurate are Joseph Pantginis's stock ratings?

About 44% of Joseph's ratings were profitable over a one-year hold, with an average return of -1.5% per rating, measured by 13Foresight from historical prices.

Q: How is Joseph ranked?

Joseph Pantginis is ranked #2339 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

H.C. Wainwright

Wall Street Analyst

★★☆☆☆

#2339

on 13Foresight · ranked by our own returns

43%

Success Rate

-0.7%

Average Return

111 of 256 calls profitable · -118.6% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 43% of Joseph Pantginis's ratings turned a profit when each position was held for 2 year — averaging -0.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

401 Buy 32 Hold 0 Sell

Joseph's Stock Coverage 97 ratings · 2026-11-14

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	2-Yr Return	vs S&P 500 ⓘ
OABI OmniAb	Oct 30, 2026	BUY	Strong Buy +59.0% avg upside 10 analysts	$11.00 115.31% Upside	-0.2%	·
VKTX Viking Therapeutics	Oct 29, 2026	BUY	Strong Buy +172.0% avg upside 31 analysts	$102.00 273.92% Upside	+8.8%	·
IOVA Iovance Biotherapeutics	Oct 29, 2026	BUY	Strong Buy +83.7% avg upside 26 analysts	$20.00 135.85% Upside	-20.3%	·
LGND Ligand Pharma	Oct 29, 2026	BUY	Strong Buy -11.1% avg upside 16 analysts	$358.00 10.98% Upside	-0.3%	·
LCTX Lineage Therap	Oct 29, 2026	BUY	Strong Buy +453.8% avg upside 16 analysts	$9.00 800.05% Upside	+1.0%	·
PROK ProKidney	Oct 28, 2026	BUY	Buy +393.1% avg upside 12 analysts	$12.00 826.64% Upside	-30.9%	·
PHAR Pharming Group	Oct 27, 2026	BUY	Strong Buy +223.0% avg upside 4 analysts	$37.00 202.55% Upside	+3.5%	·
LXRX Lexicon Pharmaceuticals	Oct 27, 2026	BUY	Buy +216.4% avg upside 10 analysts	$6.00 322.46% Upside	+25.7%	·
RIGL Rigel	Oct 26, 2026	BUY	Buy -47.4% avg upside 17 analysts	$85.00 65.76% Upside	-9.7%	·
NVCT Nuvectis Pharma	Oct 26, 2026	BUY	Strong Buy +58.5% avg upside 7 analysts	$39.00 111.11% Upside	+7.8%	·
ANAB AnaptysBio	Oct 26, 2026	BUY	Strong Buy +48.7% avg upside 26 analysts	$95.00 96.83% Upside	-5.2%	·
TVTX Travere Therapeutics	Oct 26, 2026	BUY	Strong Buy +15.5% avg upside 22 analysts	$67.00 32.96% Upside	+1.4%	·
BLRX Bioline RX Ltd Sponsored ADR	Oct 23, 2026	BUY	Strong Buy +389.9% avg upside 6 analysts	$26.00 1206.47% Upside	-27.0%	·
GUTS Fractyl Health, Inc.	Oct 22, 2026	BUY	Strong Buy +1326.9% avg upside 7 analysts	$8.00 719.35% Upside	-20.3%	·
ATNM Actinium Pharmaceuticals	Oct 20, 2026	BUY	Strong Buy +364.2% avg upside 11 analysts	$4.00 170.33% Upside	+10.0%	·
CYTK Cytokinetics	Oct 19, 2026	BUY	Strong Buy +43.4% avg upside 36 analysts	$140.00 122.27% Upside	-10.4%	·
CLNN Clene	Oct 19, 2026	BUY	Strong Buy +749.8% avg upside 11 analysts	$31.00 709.35% Upside	+33.1%	·
ANL Adlai Nortye Ltd. Sponsored ADR	Oct 16, 2026	BUY	Strong Buy +181.2% avg upside 9 analysts	$20.00 109.33% Upside	-5.0%	·
KRYS Krystal Biotech	Oct 15, 2026	BUY	Strong Buy -15.2% avg upside 20 analysts	$361.00 8.58% Upside	-7.5%	·
PDSB PDS Biotechnology	Oct 15, 2026	BUY	Strong Buy +867.3% avg upside 11 analysts	$5.00 247.22% Upside	-32.9%	·
BMEA Biomea Fusion	Oct 14, 2026	BUY	Strong Buy +1905.7% avg upside 16 analysts	$4.00 525.42% Upside	-30.1%	·
CAPR Capricor Therapeutics	Oct 06, 2026	HOLD	Strong Buy +332.6% avg upside 12 analysts	—	+23.0%	·
CLDX Celldex	Oct 05, 2026	BUY	Strong Buy +42.9% avg upside 28 analysts	$64.00 112.54% Upside	-11.5%	·
TNYA Tenaya Therapeutics	Oct 05, 2026	BUY	Strong Buy +2621.8% avg upside 11 analysts	$3.00 716.49% Upside	-36.2%	·
STTK Shattuck Labs	Oct 01, 2026	BUY	Strong Buy +276.2% avg upside 16 analysts	$14.00 151.78% Upside	-32.0%	·
QTTB Q32 Bio	Sep 30, 2026	BUY	Buy +523.8% avg upside 28 analysts	$36.00 304.03% Upside	+6.7%	·
NAMS NewAmsterdam Pharma Company	Sep 29, 2026	BUY	Strong Buy +136.0% avg upside 19 analysts	$52.00 159.31% Upside	-15.4%	·
TPST Tempest Therapeutics	Sep 24, 2026	BUY	Buy +4215.3% avg upside 18 analysts	$7.00 1312.62% Upside	-55.3%	·
FR:ALSEN Sensorion SAS	Sep 24, 2026	BUY	Strong Buy +217.9% avg upside 6 analysts	$32.00 270.43% Upside	+17.1%	·
ATYR aTyr Pharma	Sep 24, 2026	HOLD	Buy +69.8% avg upside 17 analysts	—	·	·
ARMP Armata Pharmaceuticals	Sep 23, 2026	BUY	Strong Buy +326.9% avg upside 4 analysts	$15.00 357.36% Upside	+4.4%	·
CMPX Compass Therapeutics	Sep 23, 2026	BUY	Strong Buy +831.7% avg upside 20 analysts	$12.00 1425.85% Upside	-34.2%	·
TSE:SVA Sernova	Sep 14, 2026	BUY	Strong Buy +1862.2% avg upside 3 analysts	$1.00 852.39% Upside	+0.0%	·
KURA Kura Oncology	Sep 09, 2026	BUY	Strong Buy +155.5% avg upside 27 analysts	$40.00 289.89% Upside	-35.7%	·
CVKD Cadrenal Therapeutics, Inc.	Sep 01, 2026	BUY	Strong Buy +2844.2% avg upside 2 analysts	$13.00 1219.86% Upside	-4.6%	·
AU:BOT Botanix Pharmaceuticals Limited	Aug 26, 2026	BUY	Strong Buy +9900.1% avg upside 1 analyst	$1.00 9900.06% Upside	-50.0%	·
BCDA BioCardia	Aug 24, 2026	BUY	Strong Buy +1700.3% avg upside 5 analysts	$25.00 2803.66% Upside	-10.4%	·
APRE Aprea Therapeutics	Aug 13, 2026	BUY	Buy +4003.5% avg upside 8 analysts	$1.20 147.54% Upside	-22.8%	·
CALC CalciMedica	Aug 12, 2026	HOLD	Buy +1661.3% avg upside 10 analysts	—	+95.2%	·
NEUP Neuphoria Therapeutics	Jul 27, 2026	HOLD	Strong Buy +558.2% avg upside 6 analysts	—	-27.8%	·
KAPA Kairos Pharma, Ltd.	Jul 27, 2026	BUY	Strong Buy +5513.2% avg upside 4 analysts	$84.00 15749.06% Upside	-77.9%	·
EWTX Edgewise Therapeutics	Jun 16, 2026	BUY	Strong Buy +18.0% avg upside 16 analysts	$45.00 15.68% Upside	+30.8%	·
LSTA Lisata Therapeutics	May 18, 2026	HOLD	Buy +1169.5% avg upside 11 analysts	—	-61.2%	·
HLSQ Tessera Defense and Homeland Security	Mar 09, 2026	HOLD	Buy +14451.8% avg upside 4 analysts	—	·	·
FBIO Fortress Biotech	Feb 23, 2026	BUY	Strong Buy +311.4% avg upside 12 analysts	$17.00 785.44% Upside	-46.4%	·
YARW Yarrow Bioscience	Dec 17, 2025	HOLD	Strong Buy +38.5% avg upside 9 analysts	—	+9.6%	·
SE:MVIR Medivir AB	Oct 23, 2025	BUY	Strong Buy +2592.9% avg upside 2 analysts	$54.00 3383.95% Upside	+174.5%	·
XBIO Xenetic Biosciences	Aug 13, 2025	HOLD	Hold 2 analysts	—	-39.8%	·
GNTA Genenta Science SpA Sponsored ADR	Jul 02, 2025	BUY	Strong Buy +2433.9% avg upside 3 analysts	$25.00 3943.32% Upside	-82.9%	·
PTN Palatin Technologies	Jun 20, 2025	HOLD	Strong Buy +2243.3% avg upside 4 analysts	—	-21.6%	·
DE:MDG1 Medigene	Apr 08, 2025	HOLD	Strong Buy +79900.0% avg upside 2 analysts	—	·	·
BIORQ Biora Therapeutics	Mar 31, 2025	HOLD	Strong Buy +22439999900.0% avg upside 7 analysts	—	·	·
BPTSY Biophytis	Feb 26, 2025	HOLD	Sell +20.9% avg upside 2 analysts	—	-85.6%	·
BRRGF Oncoinvent ASA	Feb 26, 2025	HOLD	Hold 1 analyst	—	·	·
TRAW Traws Pharma	Sep 25, 2024	HOLD	Buy +10541.9% avg upside 10 analysts	—	-92.0%	·
PBLA Panbela Therapeutics	Sep 25, 2024	HOLD	Buy +4504404.4% avg upside 3 analysts	—	·	·
MBIO Mustang Bio	May 16, 2024	BUY	Strong Buy +1587.1% avg upside 5 analysts	$2.00 399.96% Upside	-96.0%	·
GB:OXB Oxford BioMedica	Nov 29, 2023	HOLD	Buy +31.5% avg upside 5 analysts	—	+266.3%	·
IMVIF IMV	Aug 08, 2023	HOLD	Buy +2452638974.9% avg upside 7 analysts	—	·	·
XNCR Xencor	Aug 07, 2023	HOLD	Strong Buy +31.8% avg upside 29 analysts	—	-69.8%	·
HURA TuHURA Biosciences	Feb 09, 2023	HOLD	Strong Buy +376.7% avg upside 8 analysts	—	·	·
BYSI Beyondspring	Apr 14, 2022	HOLD	Buy +1152.3% avg upside 8 analysts	—	-4.6%	·
PVLA Palvella Therapeutics	Nov 02, 2021	BUY	Strong Buy +17.8% avg upside 28 analysts	$9.00 93.83% Downside	-94.5%	·
SSKN Strata Skin Sciences	Aug 23, 2021	BUY	Strong Buy +5999900.0% avg upside 5 analysts	$3.00 2999900.02% Upside	-55.5%	·
GB:0RIS Targovax ASA	Aug 18, 2021	BUY	Strong Buy +16.7% avg upside 1 analyst	$12.18 16.73% Upside	·	·
NL:PHARM Pharming Group	Aug 05, 2021	BUY	Strong Buy +202.9% avg upside 4 analysts	$3.10 184.59% Upside	+24.1%	·
AU:PTX Prescient Therapeutics Limited	Nov 27, 2019	HOLD	Hold 1 analyst	—	·	·
IRD Opus Genetics	Aug 07, 2019	HOLD	Strong Buy +231.4% avg upside 25 analysts	$3.00 18.31% Downside	-52.4%	·
OTLC Oncotelic Therapeutics	Apr 22, 2019	HOLD	Strong Buy +21615.3% avg upside 5 analysts	—	+222.2%	·
SCPX Scorpius Holdings	Nov 16, 2018	BUY	Strong Buy +3051983.3% avg upside 11 analysts	$6.00 999900.07% Upside	·	·
SLS SELLAS Life Sciences Group	Jul 31, 2018	BUY	Strong Buy +606.8% avg upside 16 analysts	$4.00 58.63% Downside	-93.8%	·
SNGX Soligenix	Mar 16, 2018	HOLD	Buy +814.5% avg upside 6 analysts	$2.70 658.70% Upside	·	·
RBSH Rebus Holdings	Jun 02, 2017	BUY	Strong Buy +1999899.9% avg upside 2 analysts	—	·	·
IMNN Imunon	Apr 10, 2017	BUY	Strong Buy +1512.9% avg upside 11 analysts	$21.00 2207.70% Upside	·	·
TGTX TG Therapeutics	Dec 07, 2016	BUY	Strong Buy -30.0% avg upside 20 analysts	$33.00 46.08% Downside	-2.9%	·
VSTM Verastem	Dec 07, 2016	HOLD	Strong Buy +55.8% avg upside 24 analysts	$2.00 79.49% Downside	+276.3%	·
SRNE Sorrento Therapeutics	Dec 05, 2016	BUY	Strong Buy +8333233.3% avg upside 7 analysts	$15.00 4999899.98% Upside	·	·
NTBLQ Notable Labs	Nov 29, 2016	BUY	Buy +809999900.0% avg upside 12 analysts	$17.00 1699999900.01% Upside	·	·
ENLV Enlivex	Nov 29, 2016	BUY	Strong Buy +2278.3% avg upside 4 analysts	$15.00 742.60% Upside	·	·
IMMP Immutep	Nov 28, 2016	BUY	Strong Buy +311.2% avg upside 7 analysts	$6.00 96.15% Upside	-1.2%	·
PALI Palisade Bio	Nov 28, 2016	BUY	Strong Buy +2087.9% avg upside 16 analysts	$15.60 1244.88% Upside	·	·
IMUC ImmunoCellular Therapeutics	Nov 23, 2016	BUY	Strong Buy +7475.7% avg upside 3 analysts	$8.00 10919.20% Upside	·	·
CFRXQ ContraFect	Nov 09, 2016	HOLD	Buy +10969999900.0% avg upside 10 analysts	$2.20 219999900.00% Upside	·	·
REGN Regeneron	Oct 31, 2016	BUY	Strong Buy -12.1% avg upside 60 analysts	$520.00 43.99% Downside	-1.7%	·
DARE Daré Bioscience	Oct 18, 2016	BUY	Strong Buy +1692.2% avg upside 15 analysts	$2.50 257.32% Upside	·	·
DCOY Decoy Therapeutics	Sep 13, 2016	BUY	Strong Buy +2381.3% avg upside 7 analysts	$26.00 2329.92% Upside	·	·
CNSY Cerenome	Jun 27, 2016	BUY	Strong Buy +1547.0% avg upside 11 analysts	$11.00 547.04% Upside	·	·
CRIS Curis	Feb 29, 2016	BUY	Strong Buy +2085.2% avg upside 12 analysts	$5.00 733.41% Upside	·	·
TLOG Tetralogic Pharma	Jan 07, 2016	BUY	Strong Buy +433333233.4% avg upside 3 analysts	$1.00 99999899.98% Upside	·	·
MDGL Madrigal Pharmaceuticals	Oct 21, 2015	HOLD	Strong Buy +20.2% avg upside 34 analysts	$35.00 91.86% Downside	+73.8%	·
CANF Can-Fite BioPharma	May 31, 2015	HOLD	Strong Buy +215.7% avg upside 8 analysts	$3.30 103.70% Upside	·	·
LITS Lite Strategy	Mar 23, 2015	HOLD	Strong Buy +865.5% avg upside 13 analysts	$2.50 123.31% Upside	·	·
LADX LadRx	Sep 30, 2013	BUY	Strong Buy +64445.4% avg upside 5 analysts	$9.00 81718.10% Upside	·	·
AGEN Agenus	Nov 09, 2012	BUY	Strong Buy +72.3% avg upside 19 analysts	—	·	·
AMRN Amarin	Sep 11, 2012	BUY	Buy -28.6% avg upside 18 analysts	$26.00 114.73% Upside	-86.7%	·
MBOT Microbot Medical	Jul 24, 2012	BUY	Strong Buy +424.2% avg upside 9 analysts	$5.00 358.75% Upside	·	·
BGMS Bio Green Med Solution	Feb 04, 2010	BUY	Strong Buy +1372.3% avg upside 7 analysts	$7.00 677.86% Upside	·	·

🔒 92 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Joseph Pantginis — Frequently Asked Questions

How accurate are Joseph Pantginis's stock ratings?

Based on the calls 13Foresight could measure, about 44% of Joseph's ratings were profitable over a one-year hold, with an average return of -1.5% per rating, or -117.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Joseph ranked on 13Foresight?

Joseph Pantginis is currently ranked #2339 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Joseph cover?

Joseph most recently has ratings on OABI, VKTX, IOVA, LGND, LCTX, PROK, PHAR, LXRX, RIGL, NVCT, ANAB, TVTX and 85 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Joseph Pantginis

Rating Distribution

Welcome to 13Foresight!